| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |